Supplemental material, sj-docx-2-tct-10.1177_15330338231154092 for Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL by Yan Wang, Fei Ran, Jin Lin, Jing Zhang and Dan Ma in Technology in Cancer Research & Treatment</p
Myeloproliferative neoplasms are clonal diseases of hematopoietic stem cells characterized by myeloi...
International audienceMyeloproliferative neoplasms are clonal hematopoietic stem cell disorders char...
Somatic mutations in JAK2, calreticulin, and MPL genes drive myeloproliferative neoplasms (MPN), and...
Supplemental material, sj-tif-1-tct-10.1177_15330338231154092 for Genetic and Clinical Characteristi...
BACKGROUND: Philadelphia negative myeloproliferative neoplasms (MPNs) are characterized by frequent ...
Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are clonal disorders of a hemato...
BACKGROUND: Philadelphia negative myeloproliferative neoplasms (MPNs) are characterized by frequent ...
Mutations in JAK2, MPL and CALR are highly relevant to the Philadelphia chromosome (Ph)-negative mye...
Myeloproliferative neoplasms (MPNs) are clonal disorders characterized by increased production of ma...
Chronic myeloproliferative neoplasms (MPNs) are hematopoietic stem cell neoplasms with driver events...
Introduction: The myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases characte...
WOS: 000399199200015PubMed ID: 28360451Philadelphia-negative myeloproliferative neoplasms (MPNs) wer...
BackgroundThe discovery of Janus kinase 2 (JAK2)-V617F has provided important insight into the patho...
The identification of the JAK2V617F mutation in several distinct myeloproliferative neoplasms (MPNs)...
Mutations of JAK2V617F, CALR, and MPL genes confirm the diagnosis of myeloproliferative neoplasm (MP...
Myeloproliferative neoplasms are clonal diseases of hematopoietic stem cells characterized by myeloi...
International audienceMyeloproliferative neoplasms are clonal hematopoietic stem cell disorders char...
Somatic mutations in JAK2, calreticulin, and MPL genes drive myeloproliferative neoplasms (MPN), and...
Supplemental material, sj-tif-1-tct-10.1177_15330338231154092 for Genetic and Clinical Characteristi...
BACKGROUND: Philadelphia negative myeloproliferative neoplasms (MPNs) are characterized by frequent ...
Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are clonal disorders of a hemato...
BACKGROUND: Philadelphia negative myeloproliferative neoplasms (MPNs) are characterized by frequent ...
Mutations in JAK2, MPL and CALR are highly relevant to the Philadelphia chromosome (Ph)-negative mye...
Myeloproliferative neoplasms (MPNs) are clonal disorders characterized by increased production of ma...
Chronic myeloproliferative neoplasms (MPNs) are hematopoietic stem cell neoplasms with driver events...
Introduction: The myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases characte...
WOS: 000399199200015PubMed ID: 28360451Philadelphia-negative myeloproliferative neoplasms (MPNs) wer...
BackgroundThe discovery of Janus kinase 2 (JAK2)-V617F has provided important insight into the patho...
The identification of the JAK2V617F mutation in several distinct myeloproliferative neoplasms (MPNs)...
Mutations of JAK2V617F, CALR, and MPL genes confirm the diagnosis of myeloproliferative neoplasm (MP...
Myeloproliferative neoplasms are clonal diseases of hematopoietic stem cells characterized by myeloi...
International audienceMyeloproliferative neoplasms are clonal hematopoietic stem cell disorders char...
Somatic mutations in JAK2, calreticulin, and MPL genes drive myeloproliferative neoplasms (MPN), and...